We know that scientists rely on review papers to keep current with expert perspectives on their field. That’s why we include high-impact, comprehensive prostate cancer review papers in every issue of Prostate Cell News. We then archive these hand-selected review papers here on the Prostate Cell News reviews board. Sort through the list by title, journal, or date, or just browse through them all to catch up with the latest perspectives in prostate cancer research. You can also submit a recent review paper to our editors, and we’ll try to include it in the next issue of Prostate Cell News.
Title   Journal   Publication Date   Newsletter Issue  
An Update on Vitamin D Signaling and Cancer
Carlberg, C.; Munoz, A.
Semin Cancer Biol 2020-05-03 11.21 | Jun 12
Photodynamic Diagnosis and Therapy for Urothelial Carcinoma and Prostate Cancer: New Imaging Technology and Therapy
Fukuhara, H.; Yamamoto, S.; Karashima, T.; Inoue, K.
Int J Clin Oncol 2020-05-26 11.19 | May 29
Signaling through Estrogen Receptors Modulates Long Non-Coding RNAs in Prostate Cancer
Nanni, S.; Bacci, L.; Aiello, A.; Salis, C.; Et al.
Mol Cell Endocrinol 2020-05-13 11.18 | May 22
Challenges, Applications and Future Directions of Precision Medicine in Prostate Cancer – The Role of Organoids and Patient-Derived Xenografts
Joshi, A.; Roberts, M.; Alinezhad, S.; Williams, E.; Vela, I.
BJU Int 2020-05-08 11.17 | May 15
The Diverse Roles of SPOP in Prostate Cancer and Kidney Cancer
Wang, Z.; Song, Y.; Ye, M.; Dai, X.; Zhu, X.; Wei, W.
Nat Rev Urol 2020-04-30 11.16 | May 8
Growth Modulatory Role of Zinc in Prostate Cancer and Application to Cancer Therapeutics
To, P.; Do, M.; Cho, J.; Jung, C.
Int J Mol Sci 2020-04-23 11.15 | May 1
The Genetic Landscapes of Urological Cancers and Their Clinical Implications in the Era of High-Throughput Genome Analysis
Light, A.; Ahmed, A.; Dasgupta, P.; Elhage, O.
BJU Int 2020-04-19 11.14 | Apr 24
Flavonoids as Epigenetic Modulators for Prostate Cancer Prevention
Izzo, S.; Naponelli, V.; Bettuzzi, S.
Nutrients 2020-04-06 11.13 | Apr 17
Targeted Radionuclide Therapy of Prostate Cancer-From Basic Research to Clinical Perspectives
Czerwińska, M.; Bilewicz, A.; Kruszewski, M.; Wegierek-Ciuk, A.; Lankoff, A.
Molecules 2020-04-10 11.13 | Apr 17
Anticancer Properties and Mechanism of Action of the Quassinoid Ailanthone
Bailly, C.
Phytother Res 2020-04-01 11.12 | Apr 3
NF-κB Signaling Promotes Castration-Resistant Prostate Cancer Initiation and Progression
Thomas-Jardin, S.; Dahl, H.; Nawas, A.; Bautista, M.; Delk, N.
Pharmacol Ther 2020-03-19 11.11 | Mar 27
Cellular Rewiring in Lethal Prostate Cancer: The Architect of Drug Resistance
Carceles-Cordon, M.; Kelly, W.; Gomella, L.; Knudsen, K.; Rodriguez-Bravo, V.; Domingo-Domenech, J.
Nat Rev Urol 2020-03-16 11.10 | Mar 20
Mechanism of Anti-Cancer Activity of Curcumin on Androgen-Dependent and Androgen-Independent Prostate Cancer
Wahab, N.; Lajis, N.; Abas, F.; Othman, I.; Naidu, R.
Nutrients 2020-03-02 11.09 | Mar 13
Knowing What’s Growing: Why Ductal and Intraductal Prostate Cancer Matter
Lawrence, M.; Porter, L.; Clouston, D.; Murphy, D.; Et al.
Sci Transl Med 2020-03-04 11.08 | Mar 6
Metastasis-Associated Protein 1-Mediated Antitumor and Anticancer Activity of Dietary Stilbenes for Prostate Cancer Chemoprevention and Therapy
Levenson, A.
Semin Cancer Biol 2020-02-29 11.08 | Mar 6
All Change in the Prostate Cancer Diagnostic Pathway
Lomas, D.; Ahmed, H.
Nat Rev Clin Oncol 2020-02-28 11.07 | Feb 28
Tumor Metabolism and Its Unique Properties in Prostate Adenocarcinoma
Bader, D.; McGuire, S.
Nat Rev Urol 2020-02-28 11.07 | Feb 28
Considering the Role of Radical Prostatectomy in 21st Century Prostate Cancer Care
Costello, A.
Nat Rev Urol 2020-02-21 11.07 | Feb 28
DNA-PK, Nuclear mTOR, and the Androgen Pathway in Prostate Cancer
Giguère, V.
Trends Cancer 2020-02-18 11.06 | Feb 21
Focal Therapy for Localized Prostate Cancer in the Era of Routine Multi-Parametric MRI
Connor, M.; Gorin, M.; Nigam, A.
Prostate Cancer Prostatic Dis 2020-02-12 11.05 | Feb 14
Engineering Prostate Cancer from Induced Pluripotent Stem Cells-New Opportunities to Develop Preclinical Tools in Prostate and Prostate Cancer Studies
Hepburn, A.; Cole Sims, C.; Buskin, A.; Heer, R.
Int J Mol Sci 2020-01-30 11.04 | Feb 7
PIM Kinase Inhibition: Co-Targeted Therapeutic Approaches in Prostate Cancer
Luszczak, S.; Kumar, C.; Sathyadevan, V.; Simpson, B.; Et al.
Signal Transduct Target Ther 2020-01-31 11.03 | Jan 31
Advances of Zinc Signaling Studies in Prostate Cancer
Li, D.; Stovall, D.; Wang, W.; Sui, G.
Int J Mol Sci 2020-01-19 11.02 | Jan 24
Tumor Innervation and Neurosignaling in Prostate Cancer
March, B.; Faulkner, S.; Jobling, P.; Steigler, A.; Blatt, A.; Denham, J.; Hondermarck, H.
Nat Rev Urol 2020-01-14 11.01 | Jan 17
TRPV6 as a Target for Cancer Therapy
Stewart, J.
J Cancer 2020-01-01 11.00 | Jan 10
Extracellular Vesicles in Urological Malignancies: An Update
Linxweiler, J.; Junker, K.
Nat Rev Urol 2019-12-11 10.48 | Dec 20
Noncanonical Wnt as a Prognostic Marker in Prostate Cancer: “You Can’t Always Get What You Wnt”
Fisher, R.; Pleskow, H.; Bedingfield, K.; Miyamoto, D.
Expert Rev Mol Diagn 2019-12-12 10.47 | Dec 13
The Epigenetic and Transcriptional Landscape of Neuroendocrine Prostate Cancer Davies, A.; Zoubeidi, A..; Seth, L. Endocr Relat Cancer 2019-12-01 10.46 | Dec 6
Structure and Function of the Nuclear Receptor Superfamily and Current Targeted Therapies of Prostate Cancer Porter, B.; Ortiz, M.; Bratslavsky, G.; Kotula, L. Cancers 2019-11-23 10.45 | Nov 29
Androgen-Regulated MicroRNAs (AndroMiRs) as Novel Players in Adipogenesis Jansen, J.; Greither, T.; Behre, H. Int J Mol Sci 2019-11-16 10.44 | Nov 22
Cytoreductive Treatment Strategies for De Novo Metastatic Prostate Cancer Connor, M.; Shah, T.; Horan, G.; Bevan, C.; Winkler, M.; Ahmed, H. Nat Rev Clin Oncol 2019-11-11 10.43 | Nov 15
Radium-223 Mechanism of Action: Implications for Use in Treatment Combinations Morris, M.; Corey, E.; Guise, T.; Gulley, J.; Et al. Nat Rev Urol 2019-11-11 10.43 | Nov 15
Plasma Androgen Receptor in Prostate Cancer Conteduca, V.; Gurioli, G.; Brighi, N.; Lolli, C.; Schepisi, G.; Et al. Cancers 2019-11-04 10.42 | Nov 8
Beyond the Biomarker Role: Prostate-Specific Antigen (PSA) in the Prostate Cancer Microenvironment Moradi, A.; Srinivasan, S.; Clements, J.; Batra, J. Cancer Metastasis Rev 2019-10-28 10.41 | Nov 1
An Evaluation of Current Prostate Cancer Diagnostic Approaches with Emphasis on Liquid Biopsies and Prostate Cancer Mollica, V.; Di Nunno, V.; Santoni, M.; Cimadamore, A.; Et al. Expert Rev Mol Diagn 2019-10-21 10.40 | Oct 25
Chronic Prostatitis/Chronic Pelvic Pain Syndrome and Prostate Cancer: Study of Immune Cells and Cytokines Liu, Y.; Mikrani, R.; Xie, D.; Wazir, J.; Et al. Fundam Clin Pharmacol 2019-10-23 10.40 | Oct 25
Landscape of Noncoding RNA in Prostate Cancer Hua, J.; Chen, S.; He, H. Trends Genet 2019-10-14 10.39 | Oct 18
Towards Precision Oncology in Advanced Prostate Cancer Ku, SY; Gleave, ME; Beltran, H Nat Rev Urol 2019-10-11 10.38 | Oct 11
STAT3 and STAT5 Activation in Solid Cancers Igelmann, S; Neubauer, HA; Ferbeyre, G Cancers 2019-09-25 10.37 | Oct 4
Estrogen Receptors in Epithelial-Mesenchymal Transition of Prostate Cancer Di Zazzo, E; Et Al. Cancers 2019-09-23 10.36 | Sep 27
Effect of DNA Damage Response Mutations on Prostate Cancer Prognosis: A Systematic Review Swift, SL; Et Al. Future Oncol 2019-09-19 10.35 | Sep 20
Cancer Stem Cells in Prostate Cancer Radioresistance Tsao, T; Et Al. Cancer Lett 2019-09-04 10.34 | Sep 13
Emerging Therapeutic Agents for Genitourinary Cancers Zarrabi, K; Paroya, A; Wu, S J Hematol Oncol 2019-09-04 10.33 | Sep 6
Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers Santoni, M; Cimadamore, A; et al Cancers 2019-08-22 10.32 | Aug 30
Main Inflammatory Cells and Potentials of Anti-Inflammatory Agents in Prostate Cancer Hayashi, T; Fujita, K; Matsushita, M; Nonomura, N Cancers 2019-08-12 10.31 | Aug 23
Future Aspects of CDK5 in Prostate Cancer: From Pathogenesis to Therapeutic Implications Oner, M; Lin, E; Chen, MC; Hsu, FN; Shazzad Hossain Prince, GM; Chiu, KY; Teng, CJ; Yang, TY; Wang, HY; Yue, CH; Lai, CH; Hsieh, JT; Lin, H Int J Mol Sci 2019-08-09 10.30 | Aug 16
Cellular and Molecular Mechanisms underlying Prostate Cancer Development: Therapeutic Implications Testa, U; Castelli, G; Pelosi, E Adicciones 2019-06-30 10.29 | Aug 9
Novel Treatment Options in the Management of Metastatic Castration-Naïve Prostate Cancer; Which Treatment Modality to Choose? Belderbos, BPS; de Wit, R; Lolkema, MPJ; Mathijssen, RHJ; van Soest, RJ Ann Oncol 2019-07-24 10.28 | Aug 2
Molecular Underpinnings Governing Genetic Complexity of ETS-Fusion-Negative Prostate Cancer Bhatia, V; Ateeq, B Trends Mol Med 2019-07-25 10.27 | Jul 26
Cytochrome P450 3A4, 3A5, and 2C8 Expression in Breast, Prostate, Lung, Endometrial, and Ovarian Tumors: Relevance for Resistance to Taxanes van Eijk, M; Boosman, RJ; Schinkel, AH; Huitema, ADR; Beijnen, JH Cancer Chemother Pharmacol 2019-07-15 10.26 | Jul 19
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges Suva, M; Tirosh, I Mol Cell 2019-07-11 10.25 | Jul 12
Clonal Evolution and Epithelial Plasticity in the Emergence of AR-Independent Prostate Carcinoma Laudato, S; Aparicio, A; Giancotti, F Trends Cancer 2019-06-29 10.24 | Jul 5
Tumor-Proximal Liquid Biopsy to Improve Diagnostic and Prognostic Performances of Circulating Tumor Cells Buscail, E.; Chiche, L.; Laurent, C.; Vendrely, V.; Denost, Q.; Et al. Mol Oncol 2019-06-19 10.23 | Jun 28
A Decade of Clinical Development of PARP Inhibitors in Perspective Mateo, J.; Lord, C.; Tutt, A.; Balmaña, J.; Castroviejo-Bermejo, M.; Et al. Ann Oncol 2019-06-20 10.22 | Jun 21
The Role of Nuclear Receptors in Prostate Cancer Shiota, M.; Fujimoto, N.; Kashiwagi, E.; Eto, M. Cells 2019-06-17 10.22 | Jun 21
Nerve Growth Factor Induces Proliferation and Aggressiveness in Prostate Cancer Cells Donato, M.; Cernera, G.; Migliaccio, A.; Castoria, G. Cancers 2019-06-06 10.21 | Jun 14
Role of the DNA Damage Response in Prostate Cancer Formation, Progression and Treatment Zhang, W.; Incrocci, L.; van Weeden, W.; Nonnekens, J. Prostate Cancer Prostatic Dis 2019-06-13 10.21 | Jun 14
PLAC1: Biology and Potential Application in Cancer Immunotherapy Mahmoudian, J.; Ghods, R.; Nazari, M.; Jeddi-Tehrani, M.; Ghahremani, M.; Et al. Cancer Immunol Immunother 2019-06-05 10.20 | Jun 7
Prostate Cancer and Bone Metastases: The Underlying Mechanisms Wong, S.; Mohamad, N.; Giaze, T.; Chin, K.; Mohamad, N.; Ima-Nirwana, S. Int J Mol Sci 2019-05-27 10.19 | May 31
Role of Tumor-Associated Immune Cells in Prostate Cancer: Angel or Devil? Wu, S.; Wang, Y.; Su, H.; Zhao, X. Asian J Androl 2019-05-28 10.19 | May 31
Predicting Clinical Outcome of Therapy-Resistant Prostate Cancer Ma, X.; Huang, J. Proc Natl Acad Sci USA 2019-05-21 10.18 | May 24
Epigenetic Control of Gene Expression in the Normal and Malignant Human Prostate: A Rapid Response Which Promotes Therapeutic Resistance Frame, F.; Maitland, N. Int J Mol Sci 2019-05-17 10.18 | May 24
Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells Civenni, G; Albino, D; et al Front Oncol 2019-05-09 10.17 | May 17
Interplay between SOX9, Wnt/β-Catenin and Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Khurana, N; Sikka, S Int J Mol Sci 2019-04-26 10.16 | May 10
The Hippo Pathway in Prostate Cancer Salem, O; Hansen, CG Cells 2019-04-23 10.15 | May 3
Galectins in Prostate and Bladder Cancer: Tumorigenic Roles and Clinical Opportunities Martinez-Bosch, N; Rodriguez-Vida, A; Juanpere, N; Lloreta, J; Rovira, A; Albanell, J; Bellmunt, J; Navarro, P Nat Rev Urol 2019-04-23 10.14 | Apr 26
Metabolomic Profiling for the Identification of Novel Diagnostic Markers in Prostate Cancer: An Update Lucarelli, G; Loizzo, D; et al Expert Rev Mol Diagn 2019-04-08 10.13 | Apr 12
The Contributions of Prostate Cancer Stem Cells in Prostate Cancer Initiation and Metastasis Mei, W; Lin, X; Kapoor, A; Gu, Y; Zhao, K; Tang, D Cancers 2019-03-27 10.12 | Apr 5
Emerging Therapeutic Targets for Patients with Advanced Prostate Cancer Saad, F; Shore, N; Zhang, T; Sharma, S; Cho, HK; Jacobs, IA Cancer Treat Rev 2019-03-19 10.11 | Mar 29
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer Cells Izumi, K; Mizokami, A J Clin Med 2019-03-13 10.10 | Mar 22
Androgen Receptor Enhancer Usage and the Chromatin Regulatory Landscape in Human Prostate Cancers Stelloo, S; Bergman, AM; Zwart, W Endocr Relat Cancer 2019-03-01 10.09 | Mar 14
Steroid Receptor Signalings as Targets for Resveratrol Actions in Breast and Prostate Cancer De Amicis, F; Chimento, A; Montalto, FI; Casaburi, I; Sirianni, R; Pezzi, V Int J Mol Sci 2019-03-03 10.08 | Mar 8
The Influence of BRCA2 Mutation on Localized Prostate Cancer Taylor, RA; Fraser, M; Rebello, RJ; Boutros, PC; Murphy, DG; Bristow, RG; Risbridger, GP Nat Rev Urol 2019-02-26 10.07 | Mar 1
PAK4 Signaling in Health and Disease: Defining the PAK4-CREB Axis Won, SY; Park, JJ; Shin, EY; Kim, EG Exp Mol Med 2019-02-12 10.06 | Feb 22
Obesity, Inflammation, and Prostate Cancer Fujita, K; Hayashi, T; Matsushita, M; Uemura, M; Nonomura, N J Clin Med 2019-02-06 10.05 | Feb 15
Prostate Cancer-Specific Hallmarks of Amino Acids Metabolism: Towards a Paradigm of Precision Medicine Strmiska, V; Michalek, P; Eckschlanger, T; Stiborova, M; Adam, V; Krizkova, S; Heger, Z Biochim Biophys Acta 2019-01-29 10.04 | Feb 8
Role of Androgen Receptor Splice Variants, Their Clinical Relevance and Treatment Options Wach, S; Taubert, H; Cronauer, M World J Urol 2019-01-19 10.03 | Feb 1
Application of Prostate Cancer Models for Preclinical Study: Advantages and Limitations of Cell Lines, Patient-Derived Xenografts, and Three-Dimensional Culture of Patient-Derived Cells Namekawa, T; Ikeda, K; Horie-Inoue, K; Inoue, S Cells 2019-01-20 10.02 | Jan 25
Approaches to Urinary Detection of Prostate Cancer Eskra, JN; Rabizadeh, D; Pavlovich, CP; Catalona, WJ; Luo, J Prostate Cancer Prostatic Dis 2019-01-17 10.01 | Jan 18
The Anticancer Potential of Metformin on Prostate Cancer Zaidi, S; Gandhi, J; Joshi, G; Smith, NL; Khan, SA Prostate Cancer Prostatic Dis 2019-01-16 10.01 | Jan 18
Contribution of the Unfolded Protein Response to Breast and Prostate Tissue Homeostasis and Its Significance to Cancer Endocrine Response Direito, I; Fardilha, M; Helguero, LA Carcinogenesis 2018-12-28 10.00 | Jan 11
LncRNAs in Cancer: Another Layer of Complexity de Oliveira, J; Oliveira, L; Gradia, D; et al J Gene Med 2018-12-14 9.49 | Dec 21
Post-GWAS in Prostate Cancer: From Genetic Association to Biological Contribution Farashi, S; Kryza, T; Clements, J; Batra, J Nat Rev Cancer 2018-12-11 9.48 | Dec 14
Oligometastatic Prostate Cancer: Reality or Figment of Imagination Foster, C; Weichselbaum, R; Pitroda, S Cancer 2018-12-06 9.47 | Dec 7
Forkhead Box O4 Transcription Factor in Human Neoplasms: Cannot Afford to Lose the Novel Suppressor Lu, C; Yang, Z; Yu, Y; et al J Cell Physiol 2018-12-04 9.47 | Dec 7
Prostate-Specific Markers to Identify Rare Prostate Cancer Cells in Liquid Biopsies van der Toom, E; Axelrod, H; de la Rosette, J; de Reijke, T; Pienta, K; Valkenburg, K Nat Rev Urol 2018-11-27 9.46 | Nov 30
Function, Clinical Application, and Strategies of Pre-mRNA Splicing in Cancer Di, C; Syafrizayanti; Hoheisel, J; et al Cell Death Differ 2018-11-21 9.45 | Nov 23
Emerging Cell Cycle Inhibitors for Treating Metastatic Castration-Resistant Prostate Cancer Batra, A; Winquist, E Expert Opin Emerg Drugs 2018-11-13 9.44 | Nov 16
Circulating Tumor DNA in Advanced Prostate Cancer: Transitioning from Discovery to a Clinically Implemented Test Gonzalez-Billalabeitia, E; Conteduca, V; Wetterskog, D; Jayaram, A; Attard, G Prostate Cancer Prostatic Dis 2018-11-09 9.43 | Nov 9
Long Non-Coding RNAs in Prostate Cancer: Biological and Clinical Implications Das, R; Feng, F; Selth, L Mol Cell Endocrinol 2018-11-02 9.43 | Nov 9
Developments in Oligometastatic Hormone-Sensitive Prostate Cancer Chow, K; McCoy, P; Stuchbery, R; Corcoran, N; Hovens, C World J Urol 2018-10-31 9.42 | Nov 2
The Importance of Targeting Intracrinology in Prostate Cancer Management Hamid, A; Tendi, W; Sesari, S; Mochtar, C; Umbas, R; Verghaegh, G; Schalken, J World J Urol 2018-10-22 9.41 | Oct 26
Cell Death in Cancer in the Era of Precision Medicine Raschella, G; Melino, G; Gambacurta, A Genes Immun 2018-10-19 9.40 | Oct 19
PI3K Pathway in Prostate Cancer: All Resistant Roads Lead to PI3K Park, S; Kim, Y; Kim, D; So, I; Jeon, J BBA Rev Cancer 2018-10-06 9.39 | Oct 12
Mitochondrial Biology and Prostate Cancer Ethnic Disparity Xiao, J; Cohen, P; Stern, M; Odedina, F; Carpten, J; Reams, R Carcinogenesis 2018-10-09 9.39 | Oct 12
Prostate Luminal Progenitor Cells in Development and Cancer Zhang, D; Zhao, S; Li, X; Kirk, JS; Tang, DG Trends Cancer 2018-10-01 9.38 | Oct 5
Targeting Crosstalk between Nrf-2, NF-κB and Androgen Receptor Signaling in Prostate Cancer Khurana, N; Sikka, S Cancers 2018-09-25 9.37 | Sep 28
ADT with Antiandrogens in Prostate Cancer Induces Adverse Effect of Increasing Resistance, Neuroendocrine Differentiation and Tumor Metastasis Niu, Y; Guo, C; Chang, C; et al Cancer Lett 2018-09-15 9.36 | Sep 21
Therapeutic Potency of Wnt Signaling Antagonists in the Pathogenesis of Prostate Cancer, Current Status and Perspectives Pashirzad, M; Shafiee, M; Hassanian, S; et al J Cell Physiol 2018-09-07 9.35 | Sep 14
Osteoblastic Factors in Prostate Cancer Bone Metastasis Lin, S; Yu-Lee, L; Lin, S Curr Osteoporos Rep 2018-09-10 9.35 | Sep 14
New Insights in Prostate Cancer Development and Tumor Therapy: Modulation of Nuclear Receptors and the Specific Role of Liver X Receptors Bousset, L; Rambur, A; Fouache, A; Bunay, J; Morel, L; Lobaccaro, JA; Baron, S; Trousson, A; de Joussineau, C Int J Mol Sci 2018-08-28 9.34 | Sep 7
The Role of Ketoconazole in Current Prostate Cancer Care Patel, V; Liaw, B; Oh, W Nat Rev Urol 2018-08-28 9.33 | Aug 31
Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications Stall, J; Beyaert, R Cells 2018-08-29 9.33 | Aug 31
Estrogens and Prostate Cancer Dobbs, RW; Malhotra, NR; Greenwald, DT; Wang, AY; Prins, GS; Abern, MR Prostate Cancer Prostatic Dis 2018-08-21 9.32 | Aug 24
Non-Metastatic Castration Resistant Prostate Cancer: A Review of Current and Emerging Medical Therapies Alpajaro, S; Harris, J; Evans, C Prostate Cancer Prostatic Dis 2018-08-16 9.31 | Aug 17
Current Status of Androgen Receptor-Splice Variant 7 Inhibitor Niclosamide in Castrate-Resistant Prostate-Cancer Sobhani, N; Generali, D; D’Angelo, A; Aieta, M; Roviello, G Invest New Drugs 2018-08-07 9.30 | Aug 10
Landmarks in Prostate Cancer Sathianathen, N; Konety, B; Crook, J; Saad, F; Lawrentschuk, N Nat Rev Urol 2018-07-31 9.29 | Aug 3
ARD1/NAA10 Acetylation in Prostate Cancer Kuhns, KJ; Zhang, G; Wang, Z; Liu, W Exp Mol Med 2018-07-27 9.28 | Jul 27
Roles of MicroRNA in Prostate Cancer Cell Metabolism Kasomva, K; Sen, A; Paulraj, MG; Sailo, S; Raphael, V; Puro, KU; Assumi, SR; Ignacimuthu, S Int J Biochem Cell Biol 2018-07-23 9.28 | Jul 27
Diverse Roles of Fatty Acid Binding Proteins (FABPs) in Development and Pathogenesis of Cancers Amiri, M; Yousefnia, S; Forootan, F; Peymani, M; Ghaedi, K; Esfahani, M Gene 2018-07-18 9.27 | Jul 20
EMT, Stemness and Tumor Plasticity in Aggressive Variant Neuroendocrine Prostate Cancers Soundararajan, R; Paranjape, A; Maity, S; Aparicio, A; Mani, S Biochim Biophys Acta 2018-07-05 9.26 | Jul 13
Malignant Invasion of the Central Nervous System: The Hidden Face of a Poorly Understood Outcome of Prostate Cancer de Oliveira Barros, E; Meireles Da Costa, N; Palmero, C; Ribeiro, L; Nasciutti, L; Palumbo, A World J Urol 2018-07-06 9.26 | Jul 13
Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications Yegnasubramanian, S; De Marzo, A; Nelson, W Cold Spring Harb Perspect Med 2018-06-29 9.25 | Jul 6
The MicroRNA Signatures: Aberrantly Expressed miRNAs in Prostate Cancer Sharma, N; Baruah, M Clin Transl Oncol 2018-06-27 9.24 | Jun 29
Fatty Acids and Calcium Regulation in Prostate Cancer Maly, I; Hofmann, W Nutrients 2018-06-19 9.23 | Jun 22
Advances in the Computational and Molecular Understanding of the Prostate Cancer Cell Nucleus Carleton, N; Lee, G; Madabhushi, A; Veltri, R J Cell Biochem 2018-06-20 9.23 | Jun 22
Intratumor Heterogeneity in Prostate Cancer Yadav, S; Stockert, J; Hackert, V; Yadav, K; Tewari, A Urol Oncol 2018-06-07 9.22 | Jun 15
Neuroendocrine Differentiation in Prostate Cancer: Emerging Biology, Models, and Therapies Puca, L; Vlachostergios, PJ; Beltran, H Cold Spring Harb Perspect Med 2018-05-29 9.21 | Jun 8
Prostate Cancer Stem Cells: Current Understanding Skvortsov, S; Skvortsova, I; Tang, D; Dubrovska, A Stem Cells 2018-05-30 9.20 | Jun 1
Targeting Prostate Cancer: Prostate‐Specific Membrane Antigen Based Diagnosis and Therapy Wüstemann, T; Haberkorn, U; Babich, J; Mier, W Med Res Rev 2018-05-17 9.19 | May 25
Translational Models of Prostate Cancer Bone Metastasis Berish, R; Ali, A; Telmer, P; Ronald, J; Leong, H Nat Rev Urol 2018-05-16 9.18 | May 18
Systemic Treatments for High-Risk Localized Prostate Cancer Pignot, G; Maillet, d; et al Nat Rev Urol 2018-05-15 9.18 | May 18
Personalization of Prostate Cancer Therapy through Phosphoproteomics Yang, W; Freeman, M; Kyprianou, N Nat Rev Urol 2018-05-11 9.17 | May 11
eIF4E Phosphorylation in Prostate Cancer D’Abronzo, L; Ghosh, P Neoplasia 2018-05-03 9.17 | May 11
Circulating Tumor Cell Analysis in Preclinical Mouse Models of Metastasis Kitz, J; Lowes, LE; Goodale, D; Allan, AL Diagnostics (Basel) 2018-04-28 9.16 | May 4
Calcium and Nuclear Signaling in Prostate Cancer Maly, IV; Hofmann, WA Int J Mol Sci 2018-04-19 9.15 | Apr 27
Nanoparticle‐Based Targeted Cancer Strategies for Non‐Invasive Prostate Cancer Intervention Farina, NH; Zingiryan, A; Vrolijk, MA; Perrapato, SD; Ades, S; Stein, GS; Lian, JB; Landry, CC J Cell Physiol 2018-04-16 9.14 | Apr 20
Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate Ishii, K; Takahashi, S; Sugimura, Y; Watanabe, M J Clin Med 2018-04-02 9.13 | Apr 13
Delineation of the Androgen-Regulated Signaling Pathways in Prostate Cancer Facilitates the Development of Novel Therapeutic Approaches Awad, D; Pulliam, TL; Lin, C; Wilkenfeld, SR; Frigo, DE Curr Opin Pharmacol 2018-03-30 9.12 | Apr 6
Androgen Receptor Moonlighting in the Prostate Cancer Microenvironment Cioni, B; Zwart, W; Bergman, AM Endocr Relat Cancer 2018-04-04 9.12 | Apr 6
Profiling Prostate Cancer Therapeutic Resistance Wade, CA; Kyprianou, N Int J Mol Sci 2018-03-19 9.11 | Mar 23
The Role of Osteopontin in the Progression of Solid Organ Tumor Zhao, H; Chen, Q; Alam, A; Cui, J; Suen, K; Soo, A; Eguchi, S; Gu, J; Ma, D Cell Death Dis 2018-03-02 9.10 | Mar 16
Parallels between Hematopoietic Stem Cell and Prostate Cancer Disseminated Tumor Cell Regulation Cackowski, FC; Taichman, RS Bone 2018-02-26 9.09 | Mar 9
The Androgen Receptor Malignancy Shift in Prostate Cancer Copeland, BT; Pal, SK; Bolton, EC; Jones, JQ Prostate 2018-02-23 9.08 | Mar 2
Cellular Plasticity and the Neuroendocrine Phenotype in Prostate Cancer Davies, AH; Beltran, H; Zoubeidi, A Nat Rev Urol 2018-02-20 9.07 | Feb 23
Potentiating Prostate Cancer Immunotherapy with Oncolytic Viruses Lee, P; Gujar, S Nat Rev Urol 2018-02-13 9.06 | Feb 16
Integrin Inhibitors in Prostate Cancer Juan-Rivera, MC; Martínez-Ferrer, M Cancers 2018-02-06 9.05 | Feb 9
Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine Fujimura, T; Takayama, K; Takahashi, S; Inoue, S Cancers 2018-01-23 9.04 | Feb 2
CTC-Derived AR-V7 Detection as a Prognostic and Predictive Biomarker in Advanced Prostate Cancer Bastos, DA; Antonarakis, ES Expert Rev Mol Diagn 2018-01-16 9.03 | Jan 26
Prostate Cancer-Associated lncRNAs Mitobe, Y; Takayama, KI; Horie-Inoue, K; Inoue, S Cancer Lett 2018-01-09 9.02 | Jan 19
Preclinical Models of Prostate Cancer: Patient-Derived Xenografts, Organoids, and Other Explant Models Risbridger, GP; Toivanen, R; Taylor, RA Cold Spring Harb Perspect Med 2018-01-08 9.01 | Jan 12
The Molecular Biology of Prostate Cancer: Current Understanding and Clinical Implications Gandhi, J; Afridi, A; Vatsia, S; Joshi, G; Joshi, G; Kaplan, SA; Smith, NL; Ali Khan, S Prostate Cancer Prostatic Dis 2017-12-27 9.00 | Jan 5
Metabolic Vulnerabilities of Prostate Cancer: Diagnostic and Therapeutic Opportunities Zadra, G; Loda, M Cold Spring Harb Perspect Med 2017-12-11 8.48 | Dec 15
Cross-Talk between Protein Synthesis, Energy Metabolism and Autophagy in Cancer Lindqvist, LM; Tandoc, K; Topisirovic, I; Furic, L Curr Opin Genet Dev 2017-11-25 8.47 | Dec 8
Prostate Cancer: Updates on Current Strategies for Screening, Diagnosis and Clinical Implications of Treatment Modalities Tian, JY; Guo, FJ; Zheng, GY; Ahmad, A Carcinogenesis 2017-12-05 8.47 | Dec 8
Trichothecenes: Immunomodulatory Effects, Mechanisms, and Anti-Cancer Potential Wu, Q; Wang, X; Nepovimova, E; Miron, A; Liu, Q; Wang, Y; Su, D; Yang, H; Li, L; Kuca, K Arch Toxicol 2017-11-20 8.46 | Dec 1
The Dark Side of Glucose Transporters in Prostate Cancer: Are They a New Feature to Characterize Carcinomas? Gonzalez-Menendez, P; Hevia, D; Mayo, JC; Sainz, RM Int J Cancer 2017-11-21 8.45 | Nov 24
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance Shukla, S; Cyrta, J; Murphy, DA; Walczak, EG; Ran, L; Agrawal, P; xie, Y; Chen, Y; Wang, S; Zhan, Y; Li, D; Wong, EWP; Sboner, A; Beltran, H; Mosquera, JM; Sher, J; Cao, Z; Wongvipat, J; Koche, RP; Gopalan, A; Zheng, D; Rubin, MA; Scher, HI; Chi, P; Chen, Y Cancer Cell 2017-11-16 8.44 | Nov 17
Prostate Cancer Immunotherapy: Where Are We and Where Are We Going? De Velasco, MA; Uemura, H Curr Opin Urol 2017-10-31 8.43 | Nov 10
The Inflammatory Microenvironment and Microbiome in Prostate Cancer Development Sfanos, KS; Yegnasubramanian, S; Nelson, WG; Marzo, AM Nat Rev Urol 2017-10-31 8.42 | Nov 3
Targeting Immunosuppressive Adenosine in Cancer Vijayan, D; Young, A; Teng, MWL; Smyth, MJ Nat Rev Cancer 2017-10-23 8.41 | Oct 27
Alternative Mechanisms of MiR-34a Regulation in Cancer Slabáková, E; Culig, Z; Remšík, J; Souček, K Cell Death Dis 2017-10-12 8.40 | Oct 20
Natriuretic Peptides: The Case of Prostate Cancer Mezzasoma, L; Peirce, MJ; Minelli, A; Bellezza, I Molecules 2017-09-13 8.39 | Oct 13
The Role and Mechanism of Epithelial-to-Mesenchymal Transition in Prostate Cancer Progression Lo, UG; Lee, CF; Lee, MS; H, JT Int J Mol Sci 2017-09-30 8.38 | Oct 6
Cell Plasticity in Epithelial Homeostasis and Tumorigenesis Varga, J; Greten, F Nat Cell Biol 2017-09-25 8.37 | Sep 29
Circulating Steroid Hormone Variations Throughout Different Stages of Prostate Cancer Snaterse, G; Visser, J; Arlt, W; Hofland, J Endocr Relat Cancer 2017-09-18 8.36 | Sep 22
WNT Signaling in Prostate Cancer Murillo-Garzón, V; Kypta, R Nat Rev Urol 2017-09-12 8.35 | Sep 15
Extracellular Vesicles for Personalized Therapy Decision Support in Advanced Metastatic Cancers and Its Potential Impact for Prostate Cancer Soekmadji, C; Corcoran, NM; Oleinikova, I; Jovanovic, L; The Australian Prostate Cancer Collaboration BioResource; Ramm, GA; Nelson, CC; Jenster, G; Russell, PJ Prostate 2017-08-29 8.35 | Sep 15
Ethnicity and ERG Frequency in Prostate Cancer Sedarsky, J; Degon, M; Srivastava, S; Dobi, A Nat Rev Urol 2017-09-05 8.34 | Sep 8
Managing High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) and Atypical Glands on Prostate Biopsy Tosoian, JJ; Alam, R; Ball, MW; Carter, HB; Epstein, JI Nat Rev Urol 2017-08-31 8.33 | Sep 1
Implications of BCL-2 and Its Interplay with Other Molecules and Signaling Pathways in Prostate Cancer Progression Kim, JH; Lee, H; Shin, EA; Kim, DH; Choi, JB; Kim, SH Expert Opin Ther Targets 2017-08-23 8.32 | Aug 25
Implications of Bcl-2 and Its Interplay with Other Molecules and Signaling Pathways in Prostate Cancer Progression Kim, JH; Lee, H; Shin, EA; Kim, DH; Choi, JB; Kim, SH Expert Opin Ther Targets 2017-08-17 8.31 | Aug 18
Tissue Control of Androgen Action: The Ups and Downs of Androgen Receptor Expression Hunter, I; Hay, CW; Esswein, B; Watt, K; McEwen, IJ Mol Cell Endocrinol 2017-08-05 8.30 | Aug 11
Tumor Organoids as a Pre-Clinical Cancer Model for Drug Discovery Weeber, F; Ooft, SN; Dijkstra, KK; Voest, EE Cell Chem Biol 2017-07-27 8.29 | Aug 4
Recent Advances in Circulating Tumor Cells and Cell-Free DNA in Metastatic Prostate Cancer: A Review Parimi, S; Ko, JJ Expert Rev Anticancer Ther 2017-07-24 8.28 | Jul 28
Overcoming Oncogenic Mediated Tumor Immunity in Prostate Cancer Bryant, G; Wang, L; Mulholland, DJ Int J Mol Sci 2017-07-17 8.27 | Jul 21
Connexins, Important Players in the Dissemination of Prostate Cancer Cells Boucher, J; Monvoisin A; Vix, J; Mesnil, M; Thuringer, D; Debiais, F; Cronier, L Biochim Biophys Acta 2017-07-08 8.26 | Jul 14
Telomeres and Telomerase in Prostate Cancer Development and Therapy Graham, MK; Meeker, A Nat Rev Urol 2017-07-04 8.25 | Jul 7
Dose Considerations for Anti-Cancer Drugs in Metastatic Prostate Cancer Crumbaker, M; Gurney, H Prostate 2017-06-26 8.24 | Jun 30
The Stem Cell Factor (SCF)/C-KIT Signaling in Testis and Prostate Cancer Cardoso, HJ; Figueira, MI; Socorro, S J Cell Commun Signal 2017-06-27 8.24 | Jun 30
Exosomes in Diagnosis and Therapy of Prostate Cancer Pan, J; Ding, M; Xu, K; Yang, C; Mao, L Oncotarget 2017-06-16 8.23 | Jun 23
The Role of Peroxisome Proliferator-Activated Receptor Gamma in Prostate Cancer Elix, C; Pal, SK; Jones, JO Asian J Androl 2017-06-09 8.22 | Jun 16
27-Hydroxycholesterol: A Novel Player in Molecular Carcinogenesis of Breast and Prostate Cancer Marwarha, G; Raza, S; Hammer, K; Ghribi, O Chem Phys Lipids 2017-06-03 8.21 | Jun 9
Myeloid-Derived Cells in Prostate Cancer Progression: Phenotype and Prospective Therapies Lopez-Bujanda, Z; Drake, CG J Leukoc Biol 2017-05-26 8.20 | Jun 2
Magnetic Nanoformulations for Prostate Cancer Chowdhury, P; Roberts, AM; Khan, S; Hafeez, BB; Chauhan, SC; Jaggi, M; Yallapu, MM Drug Discov Today 2017-05-16 8.19 | May 26
Advances in Medical Imaging for the Diagnosis and Management of Common Genitourinary Cancers Bagheri, MH; Ahlman, MA; Lindenberg, L; Turkbey, B; Lin, J; Cahid Civelek, A; Malayeri, AA; Agarwal, PK; Choyke, PL; Folio, LR; Apolo, AB Urol Oncol 2017-05-12 8.18 | May 19
Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance Levesque, C; Nelson, PS Cold Spring Harb Perspect Med 2017-05-10 8.17 | May 12
Immunotherapy in Genitourinary Malignancies Mehta, K; Patel, K; Parikh, RA J Hematol Oncol 2017-04-24 8.16 | May 5
The ETS Family of Oncogenic Transcription Factors in Solid Tumors Sizemore, GM; Pitarresi, JR; Balakrishnan, S; Ostrowski, MC Nat Rev Cancer 2017-04-28 8.15 | Apr 28
Cellular Determinants and Microenvironmental Regulation of Prostate Cancer Metastasis Rycaj, K; Li, H; Zhou, J; Chen, X; Tang, DG Semin Cancer Biol 2017-04-11 8.14 | Apr 21
Extracellular Vesicles for Liquid Biopsy in Prostate Cancer: Where Are We and Where Are We Headed? Minciacchi, VR; Zijlstra, A; Rubin, MA; Di Vizio, D Prostate Cancer Prostatic Dis 2017-04-04 8.13 | Apr 7
Brachytherapy for Patients with Prostate Cancer: American Society of Clinical Oncology/Cancer Care Ontario Joint Guideline Update Chin, J; Rumble, RB; Kollmeier, M; Heath, E; Efstathiou, J; Dorff, T; Berman, B; Feifer, A; Jacques, A; Loblaw, DA J Clin Oncol 2017-03-27 8.12 | Mar 31
Chimeric Antigen Receptors (CARs)–a Cell and Gene Therapy Perspective Riviere, I; Sadelain, M Mol Ther 2017-03-31 8.12 | Mar 31
Low-Risk Prostate Cancer: Identification, Management, and Outcomes Moschini, M; Carroll, PR; Eggener, SE; Epstein, JI; Graefen, M; Montironi, R; Parker, C Eur Urol 2017-03-19 8.11 | Mar 24
Immune Mediators in the Tumor Microenvironment of Prostate Cancer Dai, J; Lu, Y; Roca, H; Keller, JM; Zhang, J; McCauley, LK; Keller, ET Chin J Cancer 2017-03-14 8.10 | Mar 17
Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference? Deng, J; Tang, J; Wang, G; Zhu, YS Int J Environ Res Public Health 2017-03-07 8.09 | Mar 10
Radiolabeled PSMA Small Molecule Inhibitors Will, L; Sonni, I; Kopka, K; Kratochwil, C; Giesel, FL; Haberkorn, U Q J Nucl Med Mol Imaging 2017-02-17 8.08 | Mar 3
Meta-Analysis of Metabolic Syndrome and Prostate Cancer Gacci, M; Russo, GI; De Nunzio, C; Sebastianelli, A; Salvi, M; Vignozzi, L; Tubaro, A; Morgia, G; Serni, S Prostate Cancer Prostatic Dis 2017-02-21 8.07 | Feb 24
Revisiting the Role of Wnt/β-Catenin Signaling in Prostate Cancer Schneider, JA; Logan, SK Mol Cell Endocrinol 2017-02-09 8.06 | Feb 17
Comparing the Rules of Engagement of Androgen and Glucocorticoid Receptors Claessens, F; Joniau, S; Helsen, C Cell Mol Life Sci 2017-02-06 8.05 | Feb 10
Immune Modulation by Androgen Deprivation and Radiation Therapy: Implications for Prostate Cancer Immunotherapy Kalina, JL; Neilson, DS; Comber, AP; Rauw, JM; Alexander, AS; Vergidis, J; Lum, JJ Cancers 2017-01-27 8.04 | Feb 3
Stromal Androgen Receptor in Prostate Cancer Development and Progression Leach, DA; Buchanan, G Cancers 2017-01-22 8.03 | Jan 27
Regulation of PI3K Effector Signaling in Cancer by the Phosphoinositide Phosphatases Rodgers, SJ; Ferguson, D; Mitchell, C; Ooms, L Biosci Rep 2017-01-12 8.02 | Jan 20
Androgen Receptor Splice Variants and Prostate Cancer: From Bench to Bedside Wadosky, KM; Koochekpour, S Oncotarget 2017-01-06 8.01 | Jan 12
Prostate cancer, PI3K, PTEN and Prognosis Wise, HM; Hermida, MA; Leslie, NR Conn Sci 2017-01-05 8.01 | Jan 12
Extranuclear Partners of Androgen Receptor: At the Crossroads of Proliferation, Migration, and Neuritogenesis Castoria, G; Auricchio, F; Migliaccio, A FASEB J 2016-12-28 8.00 | Jan 6
Exosomal MicroRNAs in Liquid Biopsies: Future Biomarkers for Prostate Cancer Valentino, A; Reclusa, P; Sirera, R; Giallombardo, M; Camps, C; Pauwels, P; Crispi, S; Rolfo, C Clin Transl Oncol 2017-01-04 8.00 | Jan 6
Histone Demethylase Lysine Demethylase 5B in Development and Cancer Han, M; Xu, W; Cheng, P; Jin, H; Wang, X Oncotarget 2016-12-10 7.46 | Dec 16
Blood-Based and Urinary Prostate Cancer Biomarkers: A Review and Comparison of Novel Biomarkers for Detection and Treatment Decisions Hendriks, RJ; van Oort, IM; Schalken, JA Prostate Cancer Prostatic Dis 2016-12-06 7.45 | Dec 9
Investigational Serine/Threonine Kinase Inhibitors against Prostate Cancer Metastases Festuccia, C Expert Opin Investig Drugs 2016-11-25 7.44 | Dec 2
The Role of GATA2 in Lethal Prostate Cancer Aggressiveness Rodriguez-Bravo, V; Carceles-Cordon, M; Hoshida, Y; Cordon-Cardo, C; Galsky, MD; Domingo-Domenech, J Nat Rev Urol 2016-11-22 7.43 | Nov 25
Circulating Tumor Cells as Biomarkers of Prostate, Bladder, and Kidney Cancer Gorin, MA; Verdone, JE; van der Toom, E; Bivalacqua, TJ; Allaf, ME; Pienta, KJ Nat Rev Urol 2016-11-22 7.43 | Nov 25
Androgen Synthesis in Prostate Cancer: Do All Roads Lead to Rome? Stuchbery, R; McCoy, PJ; Hovens, CM; Corcoran, NM Nat Rev Urol 2016-11-08 7.42 | Nov 18
Prostate Cancer: Developing Novel Approaches to Castration-Sensitive Disease Francini, E; Taplin ME Cancer 2016-11-01 7.41 | Nov 4
The Impact of Local Treatment of the Primary Tumor Site in Node Positive and Metastatic Prostate Cancer Patients Moschini, M; Soria, F; Briganti, A; Shariat, SF Prostate Cancer Prostatic Dis 2016-10-25 7.40 | Oct 28
The Current Evidence on Statin Use and Prostate Cancer Prevention: Are We There Yet? Alfaqih, MA; Allott, EH; Hamilton, RJ; Freeman, MR; Freedland, SJ Nat Rev Urol 2016-10-25 7.40 | Oct 28
p62 in Cancer: Signaling Adaptor Beyond Autophagy Moscat, J; Michael Karin; Maria T. Diaz-Meco Cell 2016-10-20 7.39 | Oct 21
Androgen Receptor Variation Affects Prostate Cancer Progression and Drug Resistance McCrea E; Sissung, TM; Price, DK; Chau, CH; Figg, WD Pharmacol Res 2016-10-07 7.38 | Oct 14
Alternative Splicing and Cell Survival: From Tissue Homeostasis to Disease Paronetto, MP; Passacantilli, I; Sette, C Cell Death Differ 2016-09-30 7.37 | Oct 7
Inflammatory Mediators in the Development and Progression of Benign Prostatic Hyperplasia De Nunzio, C; Presicce, F; Tubaro, A Nat Rev Urol 2016-09-30 7.37 | Oct 7
The Cohesive Metastasis Phenotype in Human Prostate Cancer Harryman, WL; Hinton, JP; Rubenstein, CP; Singh, P; Nagle, RB; Parker, SJ; Knudsen, BS; Cress, AE Biochim Biophys Acta 2016-09-24 7.36 | Sep 30
CD147 and Prostate Cancer: A Systematic Review and Meta-Analysis Peng, F; Li, H; Ning, Z; Yang, Z; Li, H; Wang, Y; Chen, F; Wu, Y PLoS One 2016-09-29 7.36 | Sep 30
Epigenetic Modulators as Therapeutic Targets in Prostate Cancer Graça, I; Pereira-Silva, E; Henrique, R; Packham, G; Crabb, SJ; Jerónimo, C Clin Epigenetics 2016-09-15 7.34 | Sep 23
Signatures of Prostate-Derived Ets Factor (PDEF) in Cancer Mahajan, N Tumour Biol 2016-09-10 7.34 | Sep 16
Importance of Estrogenic Signaling and Its Mediated Receptors in Prostate Cancer Lau, KM; To, KF Int J Mol Sci 2016-08-31 7.33 | Sep 9
Acute Severe Ulcerative Colitis: From Pathophysiology to Clinical Management Hindryckx, P; Jairath, V; D’Haens, G Nat Rev Gastroenterol Hepatol 2016-09-01 2.32 | Sep 2
The Interplay Between Cell Signaling and the Mevalonate Pathway in Cancer Mullen, PJ; Yu, R; Longo, J; Archer, MC; Penn, LZ Nat Rev Cancer 2016-08-26 7.31 | Aug 26
The Role of α1-Adrenoceptor Antagonists in the Treatment of Prostate and Other Cancers Batty, M; Pugh, R; Rathinam, I; Simmonds J; Walker, E; Forbes, A; Anoopkumar-Dukie, S; McDermott, CM; Spencer, B; Christie, D; Chess-Williams, R Int J Mol Sci 2016-08-16 7.30 | Aug 19
Hypertension and Risk of Prostate Cancer: A Systematic Review and Meta-Analysis Liang, Z; Xie, B; Li, J; Wang, X; Wang, S; Meng, S; Ji, A; Zhu, Y; Xu, X; Zheng, X; Xie, L Sci Rep 2016-08-11 7.29 | Aug 12
A 3D Toolbox to Enhance Physiological Relevance of Human Tissue Models Picollet-D’hahan, N; Dolega, ME; Liguori, L; Marquette, C; Le Gac, S; Gidrol, X; Martin, DK Trends Biotechnol 2016-08-03 7.28 | Aug 5
Liquid Biopsy: Ready to Guide Therapy in Advanced Prostate Cancer? Hegemann, M; Stenzl, A; Bedke, J; Chi, KN; Black, PC; Todenhöfer, T BJU Int 2016-07-19 7.27 | Jul 29
Drug Discovery in Advanced Prostate Cancer: Translating Biology into Therapy Yap, TA; Smith, AD Paul Workman &; Ferraldeschi, R; Al-Lazikani, B; Workman, P; de Bono, JS Nat Rev Drug Discov 2016-07-22 7.26 | Jul 22
TRPM8 Puts the Chill on Prostate Cancer Grolez, GP; Gkika, D Pharmaceuticals 2016-07-09 7.25 | Jul 15
Aberrant Lipid Metabolism Promotes Prostate Cancer: Role in Cell Survival under Hypoxia and Extracellular Vesicles Biogenesis Deep, G; Schlaepfer, IR Int J Mol Sci 2016-07-02 7.24 | Jul 8
A Comprehensive Review of Genomic Landscape, Biomarkers and Treatment Sequencing in Castration-Resistant Prostate Cancer Seisen, T; Rouprêt, M; Gomez, F; Malouf, GG; Shariat, SF; Peyronnet, B; Spano, JP; Cancel-Tassin, G; Cussenot, O Cancer Treat Rev 2016-06-15 7.23 | Jun 24
Androgen Receptor Targeted Therapies in Castration-Resistant Prostate Cancer: Bench to Clinic Imamura, Y; Sadar, MD Int J Urol 2016-06-14 7.22 | Jun 17
The Roles of MicroRNAs in the Progression of Castration-Resistant Prostate Cancer Kojima, S; Goto, Y; Naya, Y J Hum Genet 2016-06-09 7.21 | Jun 10
Deciphering the Function of Non-Coding RNAs in Prostate Cancer Ramalho-Carvalho, J; Fromm, B; Henrique, R; Jerónimo, C Cancer Metastasis Rev 2016-05-25 7.20 | Jun 3
Oncolytic Virotherapy for Urological Cancers Delwar, Z; Zhang, K; Rennie, PS; Jia, W Nat Rev Urol 2016-05-24 7.19 | May 27
Diagnostic, Prognostic and Predictive Value of Cell-Free miRNAs in Prostate Cancer: A Systematic Review Endzelins, E; Melne, V; Kalnina, Z; Lietuvietis, V; Riekstina, U; Llorente, A; Line, A Mol Cancer 2016-05-18 7.19 | May 27
Androgen Receptor Variant-Driven Prostate Cancer: Clinical Implications and Therapeutic Targeting Antonarakis, ES; Armstrong, AJ; Dehm, SM; Luo, J Prostate Cancer Prostatic Dis 2016-05-17 7.19 | May 20
MRI-Guided Prostate Adaptive Radiotherapy – A Systematic Review McPartlin, AJ; Li, XA; Kershaw, LE; Heide, U; Kerkmeijer, L; Lawton, C; Mahmood, U; Pos, F; van, As, N; van, Herk, M; Vesprini, D; van, der, Voort, van, Zyp, J; Tree, A; Choudhury, A Radiother Oncol 2016-05-06 7.17 | May 13
Progesterone Receptor in the Prostate: A Potential Suppressor for Benign Prostatic Hyperplasia and Prostate Cancer Chen, R; Yu, Y; Dong, X J Steroid Biochem Mol Biol 2016-04-25 7.16 | May 6
A Comprehensive Review of the Role of Zinc in Normal Prostate Function and Metabolism; and Its Implications in Prostate Cancer Costello, LC; Franklin, RB Arch Biochem Biophys 2016-04-27 7.16 | May 6
The Importance of DNA Methylation in Prostate Cancer Development Massie, CE; Mills, IG; Lynch, AG J Steroid Biochem Mol Biol 2016-04-23 7.15 | Apr 29
The Role of Glycans in the Development and Progression of Prostate Cancer Munkley, J; Mills, IG; Elliott, DJ Nat Rev Urol 2016-04-19 7.14 | Apr 22
The Cross-Talk between Wnt/β-Catenin and CIP2A/Plk1 Signaling in Prostate Cancer: Promising Therapeutic Implications Cristóbal, I; Rojo, F; Madoz-Gurpide, J; García-Foncillas, J Mol Cell Biol 2016-04-18 7.14 | Apr 22
Targeting Persistent Androgen Receptor Signaling in Castration-Resistant Prostate Cancer Graham, L; Schweizer, MT Med Oncol 2016-04-04 7.12 | Apr 8
Molecular Mechanisms of Curcumin and Its Semisynthetic Analogues in Prostate Cancer Prevention and Treatment Jordan, BC; Mock, CD; Thilagavathi, R; Selvam, C Life Sci 2016-03-23 7.11 | Apr 1
Dissecting the Role of microRNAs in Prostate Cancer Metastasis: Implications for the Design of Novel Therapeutic Approaches Doldi, V; Pennati, M; Forte, B; Gandellini, P; Zaffaroni, N Cell Mol Life Sci 2016-03-12 7.10 | Mar 18
Enhancing Active Surveillance of Prostate Cancer: The Potential of Exercise Medicine Galvão, DA; Taaffe, DR; Spry, N; Gardiner, RA; Taylor, R; Risbridger, GP; Frydenberg, M; Hill, M; Chambers, SK; Stricker, P; Shannon, T; Hayne, D; Zopf, E; Newton, RU Nat Rev Urol 2016-03-08 7.09 | Mar 11
Active Surveillance for Prostate Cancer: Current Evidence and Contemporary State of Practice Tosoian, JJ; Carter, HB; Lepor, A; Loeb, S Nat Rev Urol 2016-03-08 7.09 | Mar 11
New Insights into the Androgen Biotransformation in Prostate Cancer: A Regulatory Network Among Androgen, Androgen Receptors and UGTs Qin, X; Liu, M; Wang, X Pharmacol Res 2016-02-26 7.08 | Mar 4
Current Use of PSMA-PET in Prostate Cancer Management Maurer, T; Eiber, M; Schwaiger; Gschwend, JE Nat Rev Urol 2016-02-23 7.07 | Feb 26
Clonality of Localized and Metastatic Prostate Cancer Boutros, PC; Fraser, M; van, der, Kwast, T; Bristow, RG Curr Opin Urol 2016-02-16 7.06 | Feb 19
Role of Taxanes in Advanced Prostate Cancer Cassinello, J; Carballido Rodríguez, J; Antón Aparicio, L Clin Transl Oncol 2016-02-08 7.05 | Feb 12
Regulation of Prostate Cancer Progression by the Tumor Microenvironment Shiao, SL; Chu, GC; Chung, LW Cancer Lett 2016-01-28 7.04 | Feb 5
The Importance of Non-Nuclear AR Signaling in Prostate Cancer Progression and Therapeutic Resistance Zarif, JC; Miranti, CK Cell Signal 2016-01-29 7.04 | Feb 5
Active Surveillance for Prostate Cancer: A Narrative Review of Clinical Guidelines Bruinsma, SM; Bangma, CH; Carroll, PR; Leapman, MS Nat Rev Urol 2016-01-27 7.03 | Jan 29
Prospects for the Use of Ipilimumab in Treating Advanced Prostate Cancer Wei, XX; Fong, L; Small, EJ Expert Opin Biol Ther 2016-01-25 7.03 | Jan 29
Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia and Metabolic Syndrome Vignozzi, L; Gacci, M & Maggi, M Nat Rev Urol 2016-01-12 7.02 | Jan 22
miRNAs as Novel Biomarkers in the Management of Prostate Cancer Filella, X; Foj, L Clin Chem Lab Med 2016/01/09 7.01 | Jan 15
Testosterone Therapy in Men with Prostate Cancer Kaplan, AL; Hu, JC; Morgentaler, A; Mulhall, JP; Schulman, CC; Montorsi, F Eur Urol 2015-12-21 7.00 | Jan 8
Prostate Cancer in Men of African Origin McGinley, KF; Tay, KJ; Moul, JW Nat Rev Urol 2015-12-31 7.00 | Jan 8
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer Karamouzis, VM; Papavassiliou, KA; Adamopoulos, C; Papavassiliou, AG Trends Cancer 2015-12-31 7.00 | Jan 8
Androgen–Glucocorticoid Interactions in the Era of Novel Prostate Cancer Therapy Narayanan, S; Srinivas, S; Feldman, D Nat Rev Urol 2015-12-08 6.48 | Dec 18
Immunotherapy in Prostate Cancer: Challenges and Opportunities Noguchi, M; Koga, N; Moriya, F; Itoh, K Immunotherapy 2015-12-07 6.47 | Dec 11
Linking Obesogenic Dysregulation to Prostate Cancer Progression Taylor, RA; Lo, J; Ascui, N; Watt, MJ Endocr Connect 2015-12-01 6.47 | Dec 11
Virus Encoded Circulatory miRNAs for Early Detection of Prostate Cancer Kim, J; Yun, SJ; Kim, WJ BMC Urol 2015-11-26 6.46 | Dec 4
Persistent Androgen Receptor Addiction in Castration-Resistant Prostate Cancer Schweizer, MT; Yu, EY J Hematol Oncol 2015-11-13 6.45 | Nov 27
Epithelial–Mesenchymal Transition in Prostatic Disease Broster, SA; Kyprianou, N Future Oncol 2015-11-09 6.44 | Nov 20
Emerging Mechanisms of Resistance to Androgen Receptor Inhibitors in Prostate Cancer Watson, PA; Arora, VK; Sawyers, CL Nat Rev Cancer 2015-11-13 6.43 | Nov 13
Notch Signaling in Prostate Cancer: Refining a Therapeutic Opportunity Su, Q; Xin, L Histol Histopathol 2015-11-02 6.42 | Nov 6
Prostate Cancer Stem Cells: The Role of Androgen and Estrogen Receptors Di Zazzo, E; Galasso, G; Giovannelli, P; Di Donato, M; Di Santi, A; Cernera, G; Rossi, V; Abbondanza, C; Moncharmont, B; Sinisi, AA; Castoria, G; Migliaccio, A Oncotarget 2015-10-24 6.41 | Oct 30
The Biology and Clinical Implications of Prostate Cancer Dormancy and Metastasis Morrissey, C; Vessella, RL; Lange, PH; Lam, HM J Mol Med 2015-10-21 6.40 | Oct 23
P-Cadherin and the Journey to Cancer Metastasis Vieira, AF; Paredes, J Mol Cancer 2015-10-06 6.39 | Oct 16
MicroRNA in Prostate Cancer Khanmi, K; Ignacimuthu, S; Paulraj, MG Clin Chim Acta 2015-09-27 6.38 | Oct 9
Clinical Implications of Hedgehog Pathway Signaling in Prostate Cancer Antonarakis, E; Suzman, D Cancers 2015-09-25 6.37 | Oct 2
Intermittent vs Continuous Androgen Deprivation Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis Magnan, S; Zarychanski, R; Pilote, L; Bernier, L; Shemilt, M; Vigneault, E; Fradet, V; Turgeon, AF JAMA Oncol 2015-09-17 6.36 | Sep 25
The Origin of Prostate Metastases: Emerging Insights Montironi, R; Santini, D; Piva, F; Santoni, M Cancer Metastasis Rev 2015-09-12 6.35 | Sep 18
Stem Cells in Genetically-Engineered Mouse Models of Prostate Cancer Shen, M; Shibata, M Endocr Relat Cancer 2015-09-04 6.34 | Sep 11
The Many Ways to Make a Luminal Cell and a Prostate Cancer Cell Goldstein, AS; Strand, DW Endocr Relat Cancer 2015-08-25 6.33 | Sep 4
Androgen Receptor and Prostate Cancer Stem Cells: Biological Mechanisms and Clinical Implications Tang, D; Deng, Q Endocr Relat Cancer 2015-08-18 6.31 | Aug 21
Stem Cells as Hormone Targets that Lead to Increased Cancer Susceptibility Prins, GS; Calderon-Gierszal, EL; Hu, WY Endocrinology 2015-08-04 6.30 | Aug 14
The Insulin-Like Growth Factor (IGF) Axis as an Anticancer Target in Prostate Cancer Heidegger, I; Massoner, P; Sampson, N; Klocker, H Cancer Lett 2015-07-28 6.29 | Aug 7
Metformin and Prostate Cancer Stem Cells: A Novel Therapeutic Target Venkateswaran, V; Klotz, LH; Mayer, MJ Prostate Cancer Prostatic Dis 2015-07-28 6.28 | Jul 31
MicroRNA in Prostate Cancer: Practical Aspects Patil, PA; Magi-Galluzzi, C Histol Histopathol 2015-07-17 6.27 | Jul 24
Metabolomic Profiling for the Identification of Novel Diagnostic Markers in Prostate Cancer Lucarelli, G; Rutigliano, M; Galleggiante, V; Giglio, A; Palazzo, S; Ferro, M; Simone, C; Bettocchi, C; Battaglia, M; Ditonno, P Expert Rev Mol Diagn 2015-07-15 6.26 | Jul 17
The Genomic Evolution of Human Prostate Cancer Neal, DE; Mitchell, T Br J Cancer 2015-06-30 6.24 | Jul 3
Circulating Long Noncoding RNA as a Potential Target for Prostate Cance Yang, J; Huang, YQ; Yu, J; Su, YJ Int J Mol Sci 2015-06-11 6.23 | Jun 26
Using Circulating Tumor Cells to Inform on Prostate Cancer Biology and Clinical Utility Armstrong, A; Garcia-Blanco, M; Gregory, S; Li, J Crit Rev Clin Lab Sci 2015-06-16 6.22 | Jun 19
Determinants of Receptor- and Tissue-Specific Actions in Androgen Signaling Pihlajamaa, P; Sahu, B; Janne, OA Endocr Rev 2015-06-08 6.21 | Jun 12
Anticancer Properties of Carotenoids in Prostate Cancer: A Review Soares, ND; Teodoro, AJ; Lotsch, PF; Granjeiro, JM; Borojevic, R Histol Histopathol 2015-06-07 6.21 | Jun 12
STIM and Orai Proteins as Novel Targets for Cancer Therapy Motiani, R; Trebak, M; Vashisht, A Am J Physiol Cell Physiol 2015-05-27 6.19 | May 29
MicroRNAs Targeting Prostate Cancer Stem Cells Gao, WQ; Chang, YL; Fang, YX Exp Biol Med 2015-05-12 6.18 | May 22
Targeted Therapies for Prostate Cancer Roviello, G; Laera, L; Fiaschi, AI; Francini, E; Petrioli, R Cancer Invest 2015-05-07 6.17 | May 15
Regulation of Tumor Cell Plasticity by the Androgen Receptor in Prostate Cancer Zoubeidi, A; Ketola, K; Davies, AH; Bishop, JL Endocr Relat Cancer 2015-05-01 6.16 | May 8
The Oncogene ERG: A Key Factor in Prostate Cancer Ladomery, MR; Adamo, P Oncogene 2015-04-27 6.15 | May 1
Characterization of the Roles of Suppressor of Cytokine Signaling-3 in Prostate Cancer Development and Progression Fu, X; Ren; L; Chen, J; Liao, K; Fu, Y; Qian, X; Xiao, J Asia Pac J Clin Oncol 2015-04-20 6.14 | Apr 24
Regulation of Vascular Endothelial Growth Factor (VEGF) in Prostate Cancer Mongang, N; de Brot, S Endocr-Relat Cancer 2015-04-13 6.13 | Apr 17
Quercetin in Prostate Cancer: Chemotherapeutic and Chemopreventive Effects, Mechanisms and Clinical Application Potential Yang, F; Song, L; Wang, H; Wang, J; Xu, Z; Xing, N Oncol Rep 2015-03-31 6.12 | Apr 10
Physical Activity and Its Mechanistic Effects on Prostate Cancer Wekesa, A; Harrison, M; Watson, RW Prostate Cancer Prostatic Dis 2015-03-24 6.11 | Mar 27
Implications of Ubiquitin Ligases in Castration-Resistant Prostate Cancer Qi, J; Fan, L; Hussain, A Curr Opin Oncol 2015-03-25 6.11 | Mar 27
Inflammation and Prostate Cancer: Friends or Foe? Taverna, G; Pedretti, E; Di Caro, G; Borrino, EM; Marchesi, F; Grizzi, F Inflamm Res 2015-03-19 6.10 | Mar 20
Roles of Ubiquitination and SUMOylation on Prostate Cancer: Mechanisms and Clinical Implications Chen, Z; Lu, W Int J Mol Sci 2015-02-27 6.09 | Mar 13
Notch Signaling in the Prostate: Critical Roles during Development and in the Hallmarks of Prostate Cancer Biology Deng, G; Ma, L; Meng, Q; Ju, X; Jiang, K; Jiang, P; Yu, Z J Cancer Res Clin Oncol 2015-03-04 6.08 | Mar 6
Enzalutamide: A Review of Its Use in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer Keating, GM Drugs Aging 2015-02-25 6.07 | Feb 27
Current and Emerging Immunotherapies for Castration-Resistant Prostate Cancer Saad, F; Miller, K Urology 2015-02-20 6.07 | Feb 27
Prostate Cancer Vaccines: The Long Road to Clinical Application Baxevanis, CN; Papamichail, M; Perez, SA Cancer Immunol Immunother 2015-02-19 6.06 | Feb 20
Molecular Imaging of Prostate Cancer: Translating Molecular Biology Approaches into the Clinical Realm Vargas, HA; Grimm, J; Donati, OF; Sala, E; Hricak, H Eur Radiol 2015-02-20 6.06 | Feb 20
Dietary Polyphenols in Prevention and Treatment of Prostate Cancer Lall, RK; Syed, DN; Adhami, VM; Khan, MI; Mukhtar, H Int J Mol Sci 2015-02-03 6.05 | Feb 13
Leading Causes of Castration-Resistant Prostate Cancer Lu, M; Lu, H; Kong, Q Expert Rev Anticancer Ther 2015/02/03 6.04 | Feb 6
Functional Significance of Aberrantly Expressed MicroRNAs in Prostate Cancer Goto, Y; Kurozumi, A; Enokida, H; Ichikawa, T; Seki, N Int J Urol 2015-01-20 6.03 | Jan 30
Clinical Significance of ERβ in Breast and Prostate Cancer from Biological Aspects Omoto, Y; Iwase, H Cancer Sci 2015-01-22 6.02 | Jan 23
Immunotherapy for Castration-Resistant Prostate Cancer: Progress and New Paradigms Quinn, DI; Shore, ND; Egawa, S; Gerritsen, WR; Fizazi, K Urol Oncol 2015-01-06 6.01 | Jan 16
Role of Diet in Prostate Cancer: The Epigenetic Link Labb&eaccute;, DP; Zadra, G; Ebot, EM; Kantoff, PW; Loda, M; Brown, M Oncogene 2014-12-22 6.00 | Jan 9
Androgen-Targeted Therapy-Induced Epithelial Mesenchymal Plasticity and Neuroendocrine Transdifferentiation in Prostate Cancer: An Opportunity for Intervention Nouri, M; Ratther, E; Stylianou, N; Nelson, CC; Hollier, BG; Williams, ED Front Immunol 2014-12-23 6.00 | Jan 9
Targeting Heat Shock Proteins in Metastatic Castration-Resistant Prostate Cancer Azad, AA; Zoubeidi, A; Gleave, ME; Chi, KN Nat Rev Urol 2014-12-16 5.48 | Dec 19
Immunotherapy in Prostate Cancer: Review of the Current Evidence Fernández-García, EM; Vera-Badillo, FE; Perez-Valderrama, B; Matos-Pita, AS; Duran, I Clin Transl Oncol 2014-12-06 5.47 | Dec 12
Advances in Systemic Therapies for Metastatic Castration-Resistant Prostate Cancer Pant, MK; Abughaban, A; Aragon-Ching, JB Future Oncol 2014-11-01 5.46 | Dec 5
Role of the Staphylococcal Nuclease and Tudor Domain Containing 1 in Oncogenesis Jariwala, N; Rajasekaran, D; Srivastava, J; Gredler, R; Akile, MA; Robertson, CL; Emdad, L; Fisher, PB; Sarkar, D Int J Oncol 2014-11-18 5.45 | Nov 28
The Epigenetics of Prostate Cancer Diagnosis and Prognosis: Update on Clinical Applications Blute, ML Jr; Damaschke, NA; Jarrard, DF Curr Opin Urol 2014-11-15 5.44 | Nov 21
Genomic Rearrangements in Prostate Cancer Barbieri, CE; Rubin, MA Curr Opin Urol 2014-11-12 5.43 | Nov 14
Models of Neuroendocrine Prostate Cancer Berman-Booty, LD; Knudsen, K Endocr Relat Cancer 2014-10-27 5.42 | Nov 7
Androgens and Androgen Receptor Signaling in Prostate Tumorigenesis Zhou, Y; Bolton, E; Jones, JO J Mol Endocrinol 2014-10-28 5.41 | Oct 31
Revisiting STAT3 Signaling in Cancer: New and Unexpected Biological Functions Yu, H; Lee; H; Herrmann, A; Buettner, R; Jove, R Nat Rev Cancer 2014-10-24 5.40 | Oct 24
MTA Family of Proteins in Prostate Cancer: Biology, Significance, and Therapeutic Opportunities Levenson, AS; Kumar, A; Zhang, X Cancer Metastasis Rev 2014-10-22 5.40 | Oct 24
Lactate Transporters in the Context of Prostate Cancer Metabolism: What Do We Know? Pértega-Gomes, N; Baltazar, F Int J Mol Sci 2014-10-13 5.39 | Oct 17
Secreted Phospholipases A2 in Cancer: Diverse Mechanisms of Action Brglez, V; Lambeau, G; Petan, T Biochimie 2014-10-05 5.38 | Oct 10
Safety of Antiandrogen Therapy for Treating Prostate Cancer Ricci, F; Buzzatti, G; Rubagotti, A; Boccardo, F Expert Opin Drug Saf 2014-10-01 5.37 | Oct 3
Epithelial Plasticity in Prostate Cancer: Principles and Clinical Perspectives Ras, R; Gregory, PA; Hollier, BG; Tilley, WD; Selth, LA Trends Mol Med 2014-09-25 5.37 | Oct 3
5-Alpha-Reductase Inhibitors in Diseases of the Prostate Carrasquillo, RJ; Nealy, SW; Wang, DS Curr Opin Endocrinol Diabetes Obes 2014-09-27 5.37 | Oct 3
Bone-Targeting Radiopharmaceuticals for the Treatment of Bone-Metastatic Castration-Resistant Prostate Cancer: Exploring the Implications of New Data Ryan, CJ; Saylor, PJ; Everly, JJ; Sartor, O Oncologist 2014-09-17 5.36 | Sep 26
Emerging Mechanisms of Enzalutamide Resistance in Prostate Cancer Claessens, F; Helsen, C; Prekovic, S; Van den Broeck, T; Slans, L; Van Poppel, H; Joniau, S Nat Rev Urol 2014-09-16 5.35 | Sep 19
Genetic Variation: Effect on Prostate Cancer Sissung, TM; Price, DK; Del Re, M; Ley, AM; Giovannetti, E; Figg, WD; Danesi, R Biochim Biophys Acta 2014-09-06 5.34 | Sep 12
Therapeutic Vaccines as a Promising Treatment Modality against Prostate Cancer: Rationale and Recent Advances Singh, BH; Gulley, JL Ther Adv Vaccines 2014-09-01 5.33 | Sep 5
SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression Cho, E; Montgomery, RB; Mostaghel, EA Endocrinology 2014-08-22 5.32 | Aug 29
Pomegranate and Its Components as Alternative Treatment for Prostate Cancer Wang, L; Martins-Green, M Int J Mol Sci 2014-08-19 5.32 | Aug 29
NUMB Inhibition of NOTCH Signaling as a Therapeutic Target in Prostate Cancer Flores, AN; McDermott, N; Meunier, A; Marignol, L Nat Rev Urol 2014-08-19 5.31 | Aug 22
DNA Damage Response and Prostate Cancer: Defects, Regulation and Therapeutic Implications Karanika, S; Karantanos, T; Li, L; Corn, PG; Thompson, TC Oncogene 2014-08-18 5.31 | Aug 22
Autophagy as a Modulator and Target in Prostate Cancer Farrow, JM; Yang, JC; Evans, CP Nat Rev Urol 2014-08-19 5.31 | Aug 22
Strategies for Targeting the Androgen Receptor Axis in Prostate Cancer Carver, BS Drug Discov Today 2014-08-10 5.30 | Aug 15
The Convergence of DNA Damage Checkpoint Pathways and Androgen Receptor Signaling in Prostate Cancer Ta, HQ; Gioeli, D Endocr Relat Cancer 2014-08-05 5.29 | Aug 8
Evolving Therapeutic Concepts in Prostate Cancer Based on Genome-Wide Analyses Duensin, S; Hohenfellner, M; Pahernik, S; Sültmann, H; Roth, W; Grüllich, C; Hadaschik; Korzeniewski, N; Georgi, B Int J Oncol 2014-07-28 5.28 | Aug 1
Personalizing Prostate Cancer Therapy: The Way Forward Cetnar, JP; Beer, TM Drug Discovery Today 2014-07-18 5.27 | Jul 25
The Role of Estrogen Receptor Beta in Prostate Cancer Christoforou, P; Christopoulos, PF; Koutsilieris, M Mol Med 2014-07-14 5.26 | Jul 18
Pathology Consultation on Prostate-Specific Antigen Testing Fantz, C; Noguez, J Am J Clin Pathol 2014-07-01 5.25 | Jul 11
Uncovering the Roles of miRNAs and Their Relationship with Androgen Receptor in Prostate Cancer ChunJiao, S; Huan, C; ChaoYang, X; GuoMei, R IUBMB Life 2014-06-30 5.24 | Jul 4
The Role of MicroRNA in Castration-Resistant Prostate Cancer Thieu, W; Tilki, D; deVere White, RW; Evans, CP Urol Oncol 2014-07-01 5.23 | Jun 27
Glycans and Galectins in Prostate Cancer Biology, Angiogenesis and Metastasis Compagno, D; Gentilini, LD; Jaworski, FM; Gonzalez Perez, I; Contrufo, G; Laderach, D Glycobiology 2014-06-16 5.22 | Jun 20
Androgen Receptor: Structure, Role in Prostate Cancer and Drug Discovery Tan, MH; Li, J; Xu, H; Melcher, K; Yong, EL Acta Pharmacologica Sinica 2014-06-09 5.21 | Jun 13
Beyond Androgen Deprivation Ancillary Integrative Strategies for Targeting the Androgen Receptor Addiction of Prostate Cancer McCarty, MF; Hejazi, J; Rastmanesh, R Integr Cancer Ther 2014-05-26 5.20 | Jun 6
High-Risk Prostate Cancer – Classification and Therapy Chang, AJ; Autio, KA; Roach, M 3rd; Scher, HI Nat Rev Clin Oncol 2014-05-20 5.19 | May 30
Evolution of Androgen Receptor Targeted Therapy for Advanced Prostate Cancer Wong, YNS; Ferraldeschi, R; Attard, G; de Bono, J Nat Rev Clin Oncol 2014-05-20 5.18 | May 23
Targeting the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer: Progresses and Prospects Ferraldeschi, R; Welti, J; Luo, J; Attard, G; de Bono, JS Oncogene 2014-05-19 5.18 | May 23
Vaccine Immunotherapy for Prostate Cancer: From Mice to Men Lubaroff, DM; Vaena, D; Brown, JA; Zehr, P; Griffith KC; Brown, E; Eastman J; Nepple, K; Kattula, A; Williams, RD Immunol Res 2014-05-22 5.18 | May 23
Circulating Tumor Cells—Monitoring Treatment Response in Prostate Cancer Miyamoto, DT; Sequist, LV; Lee, RJ Nat Rev Clin Oncol 2014-05-13 5.17 | May 16
In Vitro Modeling of the Prostate Cancer Microenvironment Ellem, SJ; De-Juan-Pardo, EL; Risbridger, GP Adv Drug Deliv Rev 2014-05-09 5.17 | May 16
The Link between Androgen Receptor Splice Variants and Castration-Resistant Prostate Cancer Sprenger, CCT; Plymate, SR Horm Cancer 2014-05-06 5.16 | May 9
Restoring TGFβ1 Pathway-Related MicroRNAs: Possible Impact in Metastatic Prostate Cancer Development Santos, JI; Teixeira, AL; Dias, F; Gomes, M; Nogueira, A; Assis, J; Medeiros, R Tumor Biol 2014-04-25 5.15 | May 2
Concept and Viability of Androgen Annihilation for Advanced Prostate Cancer Mohler, JL Cancer 2014-04-25 5.15 | May 2
Androgen Synthesis Inhibitors in the Treatment of Castration-Resistant Prostate Cancer Stein, MN; Patel, N; Bershadskiy, A; Sokoloff, A; Singer, EA Asian J Androl 2014-04-06 5.14 | Apr 25
Reconsideration of Progression to CRPC during Androgen Deprivation Therapy Mizokami, A; Namiki, M J Steroid Biochem Mol Biol 2014-04-06 5.13 | Apr 11
Overdetection in Screening for Prostate Cancer Hugosson, J; Carlsson, S Curr Opin Urol 2014-03-25 5.12 | Apr 4
Novel Bone-Targeting Agents in Prostate Cancer Albany, C; Hahn, NM Prostate Cancer Prostatic Dis 2014-03-25 5.11 | Mar 28
Androgen Receptor Antagonists for Prostate Cancer Therapy Helsen, C; Van der Broeck, T; Voet, A; Prekovic, S; Van Poppel, H; Joniau, S; Claessens, F Endocr Relat Cancer 2014-03-17 5.11 | Mar 28
TGF-β Cascade Regulation by PPP1 and Its Interactors – Impact on Prostate Cancer Development and Therapy Korrodi-Gregorio, L; Silva, JV; Snatos-Sousa, L; Freitas, MJ; Felgueiras, J; Fardilha, M J Cell Mol Med 2014-03-15 5.10 | Mar 21
Biomarkers in Prostate Cancer: What’s New? Sartori, DA; Chan, DW Curr Opin Oncol 2014-03-12 5.10 | Mar 21
Contributions of Epithelial-Mesenchymal Transition and Cancer Stem Cells to the Development of Castration Resistance of Prostate Cancer Li, P; Yang, R; Gao, WQ Mol Cancer 2014-03-12 5.09 | Mar 14
PPARγ vs TR4 Nuclear Receptor Differential Roles in Prostate Cancer and Metabolic Diseases Liu, S; Lin, SJ; Li, G; Kim, E; Chen, YT; Yang, D; Tan, E; Yong, EL; Cai, X; Chang, C Endocr Relat Cancer 2014-03-12 5.09 | Mar 14
Current Trends for the Use of Androgen Deprivation Therapy in Conjunction with Radiotherapy for Patients with Unfavorable Intermediate-Risk, High-Risk, Localized, and Locally Advanced Prostate Cancer Roach III, M Cancer 2014-03-03 5.08 | Mar 7
The Proteomics of Prostate Cancer Exosomes Drake, RR; Kislinger, T Expert Rev Proteomics 2014-02-25 5.07 | Feb 28
Small Cell Carcinoma of the Prostate Nadal, R; Schweizer, M; Kryvenko, ON; Epstein, JI; Eisenberger, MA Nat Rev Urol 2014-02-18 5.06 | Feb 21
Src Signaling Pathways in Prostate Cancer Varkaris, A; Katsiampoura, AD; Araujo, JC; Gallick, GE; Corn, PG Cancer Metastasis Rev 2014-02-13 5.05 | Feb 14
Targeting Metastatic Castration-Resistant Prostate Cancer: Mechanisms of Progression and Novel Early Therapeutic Approaches Cereda, V; Formica, V; Massimiani, G; Tosetto, L; Roselli, M Expert Opin Investig Drugs 2014-02-03 5.04 | Feb 7
Immunotherapy for Prostate Cancer: Recent Developments and Future Challenges Schweizer, MT; Drake, CG Cancer Metastasis Rev 2014-01-30 5.03 | Jan 31
Statins: Protectors or Pretenders in Prostate Cancer? Moon, H; Hill, MM; Roberts, MJ; Gardiner, RA; Brown, AJ Trends Endocrinol Metab 2014-01-22 5.02 | Jan 24
Emerging Roles of Radioresistance in Prostate Cancer Metastasis and Radiation Therapy Chang, L; Graham, PH; Hao, J; Bucci, J; Cozzi, PJ; Kearsley, JH; Li, Y Cancer Metastasis Rev 2014-01-21 5.02 | Jan 24
Metastatic Castration-Resistant Prostate Cancer (CRPC): Preclinical and Clinical Evidence for the Sequential Use of Novel Therapeutics Mukherji, D; Omlin, A; Pezaro, C; Shamseddine, A; de Bono, J Cancer Metastasis Rev 2014-01-23 5.02 | Jan 24
Insulin-Like Growth Factor Receptor-1 (IGF-IR) as a Target for Prostate Cancer Therapy Wu, J; Yu, E Cancer Metastasis Rev 2014-01-12 5.01 | Jan 17
Androgen Receptor Signaling in Prostate Cancer Culig, Z; Santer, FR Cancer Metastasis Rev 2014-01-03 5.00 | Jan 10
Estrogen Receptor Beta in Prostate Cancer: Friend or Foe? Nelson, AW; Tilley, WD; Neal, DE; Carroll, J Endocr Relat Cancer 2014-01-08 5.00 | Jan 10
Prostate Cancer: From the Pathophysiologic Implications of Some Genetic Risk Factors to Translation in Personalized Cancer Treatments Balistreri, CR; Candore, G; Lio, D; Carruba, G Cancer Gene Ther 2014-01-10 5.00 | Jan 10
Molecular Pathology and Prostate Cancer Therapeutics: From Biology to Bedside Nava Rodrigues, DN; Butler, LM; Lorente Estelles, D; de Bono, JS J Pathol 2013-12-10 4.49 | Dec 20
The Prostate-Specific Membrane Antigen: Lessons and Current Clinical Implications from 20 Years of Research Ristau, BT; O’Keefe, DS; Bacich, DJ Urol Oncol 2013-12-09 4.48 | Dec 13
Circulating Tumor Cells in Prostate Cancer Hu, B; Rochefort, H; Goldkorn, A Cancers 2013-12-04 4.48 | Dec 13
Abiraterone Acetate: A Review of Its Use in Patients with Metastatic Castration-Resistant Prostate Cancer Hoy, SM Drugs 2013-12-01 4.47 | Dec 6
Future Directions in the Prevention of Prostate Cancer Thompson Jr, IM; Cabang, AB; Wargovich, MJ Nat Rev Clin Oncol 2013-11-26 4.46 | Nov 29
Metastatic Castration-Resistant Prostate Cancer: New Therapies, Novel Combination Strategies and Implications for Immunotherapy Drake, CG; Sharma, P; Gerritsen, W Oncogene 2013-11-25 4.46 | Nov 29
Diethylstilboestrol for the Treatment of Prostate Cancer: Past, Present and Future Turo, R; Smolski, M; Esler, R; Kujawa, ML; Bromage, SJ; Oakley, N; Adeyoju, A; Brown, SCW; Brough, R; Sinclair, A; Collins, GN Scand J Urol 2013-11-21 4.45 | Nov 22
The Hurdle of Antiandrogen Drug Resistance: Drug Design Strategies Trendel, JA Expert Opin Drug Discov 2013-11-09 4.44 | Nov 15
Clinical Use of Novel Urine and Blood Based Prostate Cancer Biomarkers: A Review Dijkstra, S; Mulders, PFA; Schalken, JA Clin Biochem 2013-10-29 4.43 | Nov 8
Disruption of Prostate Epithelial Differentiation Pathways and Prostate Cancer Development Frank, SB; Miranti, CK Front Oncol 2013-10-31 4.43 | Nov 8
Androgen Receptor Co-Regulatory Networks in Castration Resistant Prostate Cancer Cheung, E; Sung, YY Endocr Relat Cancer 2013-10-23 4.42 | Nov 1
Chemotherapeutic Inhibitors in the Treatment of Prostate Cancer Deshmukh, RR; Schmitt, SM; Hwang, C; Dou, QP Expert Opin Pharmacother 2013-10-25 4.42 | Nov 1
Non-Coding RNAs in Prostate Cancer: The Long and the Short of It Bolton, EM; Tuzova, AV; Walsh, AL; Lynch, T; Perry, AS Clin Cancer Res 2013-10-21 4.41 | Oct 25
Enzalutamide: A Review of Its Use in Metastatic, Castration-Resistant Prostate Cancer Sanford, M Drugs 2013-10-01 4.40 | Oct 18
Beyond Abiraterone: New Hormonal Therapies for Metastatic Castration-Resistant Prostate Cancer Pinto, A Cancer Biol Ther 2013-10-07 4.39 | Oct 11
Molecular Imaging of Prostate Cancer with PET Jadvar, H J Nucl Med 2013-10-01 4.38 | Oct 4
Genomic Rearrangements of PTEN in Prostate Cancer Phin, S; Moore, MW; Cotter, PD Front Oncol 2013-09-27 4.37 | Sep 27
TRAIL and MicroRNAs in the Treatment of Prostate Cancer: Therapeutic Potential and Role of Nanotechnology Farooqi, AA; De Rosa, G Appl Microbiol Biotechnol 2013-09-15 4.36 | Sep 20
Intraductal Carcinoma of the Prostate: The Whole Story Zhou, M Pathology 2013-10-01 4.35 | Sep 19
Mechanisms of Androgen Receptor Activation in Castration-Resistant Prostate Cancer Sharifi, N Endocrinology 2013-09-03 4.34 | Sep 12
Epigenetic Susceptibility Factors for Prostate Cancer with Aging Damaschke, NA; Yang, B; Bhusari, S; Svaren, JP; Jarrard, DF Prostate 2013-09-02 4.34 | Sep 12
Genome-Wide Association Studies on Prostate Cancer: The End or the Beginning? Chen, R; Ren, S; Sun, Y Protein Cell 2013-08-27 4.33 | Sep 5
Salvage Therapy of Intraprostatic Failure after Radical External-Beam Radiotherapy for Prostate Cancer: A Review Alongi, F; De Bari, B; Campostrini, F; Arcangeli, S; Matei, DV; Lopci, E; Petralia, G; Bellomi, M; Chiti, A; Magrini, SM; Scorsetti, M; Orecchia, R; Jereczek-Fossa, BA Crit Rev Oncol Hematol 2013-08-14 4.32 | Aug 23
Caveola-Forming Proteins Caveolin-1 and PTRF in Prostate Cancer Nassar, ZD; Hill, MM; Parton, RG; Parat, MO Nat Rev Urol 2013-08-13 4.31 | Aug 16
Dietary Antioxidants and Prostate Cancer: A Review Vance, TM; Su, J; Fontham, ET; Koo, SI; Chun, OK Nutr Cancer 2013-08-02 4.30 | Aug 9
Experimental Evidence of Persistent Androgen-Receptor-Dependency in Castration-Resistant Prostate Cancer Kobayashi, T; Inoue, T; Kamba, T; Ogawa, O Int J Mol Sci 2013-07-26 4.29 | Aug 2
A Road Map to Comprehensive Androgen Receptor Axis Targeting for Castration-Resistant Prostate Cancer Mitsiades, N Cancer Res 2013-07-25 4.28 | Jul 26
Cell Mates: Paracrine and Stromal Targets for Prostate Cancer Therapy Sluka, P; Davis, ID Nat Rev Urol 2013-07-16 4.27 | Jul 19
The Potential Role of Lycopene for the Prevention and Therapy of Prostate Cancer: From Molecular Mechanisms to Clinical Evidence Holzapfel, NP; Holzapfel, BM; Champ, S; Feldthusen, J; Clements, J; Hutmacher, DW Int J Mol Sci 2013-07-12 4.27 | Jul 19
The Utility of Prostate-Specific Antigen in the Management of Advanced Prostate Cancer Crawford, ED; Bennett, CL; Andriole, GL; Garnick, MB; Petrylak, DP BJU Int 2013-07-04 4.26 | Jul 12
Perspectives on the Role of Isoflavones in Prostate Cancer Ahmad, A; Biersack, B; Li, Y; Bao, B; Kong, D; Ali, S; Banerjee, S; Sarkar, FH AAPS J 2013-07-04 4.25 | Jul 5
Phytochemicals from Cruciferous Vegetables; Epigenetics; and Prostate Cancer Prevention Watson, GW; Beaver, LM; Williams, DE; Dashwood, RH; Ho, E AAPS J 2013-06-26 4.24 | Jun 28
Overview of the Latest Treatments for Castration-Resistant Prostate Cancer Bishr, M; Saad, F Nat Rev Urol 2013-06-25 4.24 | Jun 28
Searching for Prostate Cancer Stem Cells: Markers and Methods Sharpe, B; Beresford, M; Bowen, R; Mitchard, J; Chalmers, AD Stem Cell Rev 2013-10-01 4.23 | Jun 21
Prostate Cancer Progression after Androgen Deprivation Therapy: Mechanisms of Castrate Resistance and Novel Therapeutic Approaches Karantanos, T; Corn, PG; Thompson, TC Oncogene 2013-06-10 4.22 | Jun 14
Androgen Receptor Functions in Castration-Resistant Prostate Cancer and Mechanisms of Resistance to New Agents Targeting the Androgen Axis Yuan, X; Cai, C; Chen, S; Chen, S; Yu, Z; Balk, SP Oncogene 2013-06-10 4.22 | Jun 14
Defining the Threshold for Significant versus Insignificant Prostate Cancer Van der Kwast, TH; Roobol, MJ Nat Rev Urol 2013-05-28 4.21 | Jun 7
Hypoxia; Notch Signaling; and Prostate Cancer Marignol, L; Rivera-Figueroa, K; Lynch, T; Hollywood, D Nat Rev Urol 2013-05-28 4.20 | May 31
Intermittent Versus Continuous Androgen Deprivation Therapy in Advanced Prostate Cancer Klotz, L Curr Urol Rep 2013-06-01 4.19 | May 24
Oxidative Stress in Prostate Cancer: Changing Research Concepts towards a Novel Paradigm for Prevention and Therapeutics Paschos, A; Pandya, R; Duivenvoorden, WC; Pinthus, JH Prostate Cancer P D 2013-05-14 4.18 | May 17
Molecular Aspects of Androgenic Signaling and Possible Targets for Therapeutic Intervention in Prostate Cancer Culig, Z; Santer, FR Steroids 2013-04-30 4.17 | May 10
Circulating MicroRNAs As Potential New Biomarkers for Prostate Cancer Sita-Lumsden, A; Dart, DA; Waxman, J; Bevan, CL Brit J Cancer 2013-04-30 4.16 | May 3
Dormancy in Solid Tumors: Implications for Prostate Cancer Ruppender, NS; Morrissey, C; Lange, PH; Vessella, RL Cancer Metastasis Rev 2013-04-24 4.15 | Apr 26
Minireview: Androgen Metabolism in Castration-Resistant Prostate Cancer Sharifi, N Mol Endocrinol 2013-04-16 4.14 | Apr 19
Molecular Mechanisms of Silibinin-Mediated Cancer Chemoprevention with Major Emphasis on Prostate Cancer Ting, H; Deep, G; Agarwal, R AAPS J 2013-04-16 4.14 | Apr 19
Advancing Precision Medicine for Prostate Cancer through Genomics Roychowdhury, S; Chinnaiyan, AM J Clin Oncol 2013-04-15 4.14 | Apr 19
Prostate Cancer Risk-Associated Genetic Markers and Their Potential Clinical Utility Xu, J; Sun, J; Zheng, SL Asian J Androl 2013-04-08 4.13 | Apr 12
Role of Androgen and Vitamin D Receptors in Endothelial Cells from Benign and Malignant Human Prostate Godoy, AS; Chung, I; Montecinos, VP; Buttyan, R; Johnson, CS; Smith, GJ Am J Physiol-Endoc M 2013-04-02 4.12 | Apr 5
Delivering RNAi Therapeutics with Non-Viral Technology: A Promising Strategy for Prostate Cancer? Guo, J; Evans, JC; O’Driscoll, CM Trends Mol Med 2013-03-14 4.11 | Mar 22
Zinc Transporters in Prostate Cancer Franz, MC; Anderle, P; Bürzle, M; Suzuki, Y; Freeman, MR; Hediger, MA; Kovacs, G Mol Aspects Med 2013-03-16 4.11 | Mar 22
Roles of MicroRNAs during Prostatic Tumorigenesis and Tumor Progression Fang, YX; Gao, WQ Oncogene 2013-03-04 4.10 | Mar 15
Validation and Clinical Utility of Prostate Cancer Biomarkers Scher, HI; Morris, MJ; Larson, S; Heller, G Nat Rev Clin Oncol 2013-03-05 4.09 | Mar 8
Proteomic Studies of Urinary Biomarkers for Prostate; Bladder and Kidney Cancers Wood, SL; Knowles, MA; Thompson, D; Selby, PJ; Banks, RE Nat Rev Urol 2013-02-26 4.08 | Mar 1
Proposed Mechanisms of Action for Prostate Cancer Vaccines Geary, SM; Lemke, CD; Lubaroff, DM; Salem, AK Nat Rev Urol 2013-02-12 4.07 | Feb 22
Eph Receptors and Their Ligands: Promising Molecular Biomarkers and Therapeutic Targets in Prostate Cancer Lisle, JE; Mertens-Walker, I; Rutkowski, R; Herington, AC; Stephenson, SA Biochim Biophys Acta 2013-02-08 4.06 | Feb 15
Local Endocrine; Paracrine and Redox Signaling Networks Impact Estrogen and Androgen Crosstalk in the Prostate Cancer Microenvironment Grubisha, MJ; DeFranco, DB Steroids 2013-02-01 4.05 | Feb 8
Manipulating the Epigenome for the Treatment of Urological Malignancies O’Rourke, CJ; Knabben, V; Bolton, E; Moran, D; Lynch, T; Hollywood, D; Perry, AS Pharmacol Ther 2013-01-24 4.04 | Feb 1
Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer Rathkopf, D; Scher, HI Cancer J 2013-01-01 4.03 | Jan 25
Aberrant PSA Glycosylation – A Sweet Predictor of Prostate Cancer Gilgunn, S; Conroy, PJ; Saldova, R; Rudd, PM; O’Kennedy, RJ Nat Rev Urol 2013-01-15 4.02 | Jan 18
Gonadotropin-Releasing Hormone Receptors as Molecular Therapeutic Targets in Prostate Cancer: Current Options and Emerging Strategies Limonta, P; Manea, M Cancer Treat Rev 2013-01-03 4.01 | Jan 11
Proteomics Role in Prostate Cancer Biomarkers Discovery and Validation Pin, E; Fredolini, C; Petricoin, EF 3rd Clin Biochem 2012-12-22 4.00 | Jan 4
Adaptation or Selection—Mechanisms of Castration-Resistant Prostate Cancer Zong, Y; Goldstein, AS Nat Rev Urol 2013-02-01 3.49 | Dec 21
Brain Metastases from Prostate Cancer: An Emerging Clinical Problem with Implications for the Future Therapeutic Scenario Caffo, O; Veccia, A; Russo, L; Galligioni, E Future Oncol 2012-12-01 3.48 | Dec 14
Sequencing the Transcriptional Network of Androgen Receptor in Prostate Cancer Chng, KR; Cheung, E Cancer Lett 2012-11-27 3.47 | Dec 7
Cells of Origin for Cancer: An Updated View from Prostate Cancer Xin, L Oncogene 2012-11-26 3.46 | Nov 30
Defective DNA Repair Systems and the Development of Breast and Prostate Cancer Kitagishi, Y; Kobayashi, M; Matsuda, S Int J Oncol 2012-11-14 3.45 | Nov 23
The Complexity of Prostate Cancer: Genomic Alterations and Heterogeneity Boyd, LK; Mao, X; Lu, YJ Nat Rev Urol 2013-11-01 3.44 | Nov 16
Modeling Prostate Cancer in Mice: Something Old; Something New; Something Premalignant; Something Metastatic Irshad, S; Abate-Shen, C Cancer Metastasis Rev 2013-06-01 3.43 | Nov 9
Progress in Emerging Therapies for Advanced Prostate Cancer Oudard, S Cancer Treat Rev 2012-10-26 3.42 | Nov 2
Characterization of Tumor Differentiation Factor (TDF) and Its Receptor (TDF-R) Sokolowska, I; Woods, AG; Gawinowicz, MA; Roy, U; Darie, CC Cell Mol Life Sci 2012-10-16 3.41 | Oct 26
Systematic Review and Meta-Analysis of COX-2 Expression and Polymorphisms in Prostate Cancer Shao, N; Feng, N; Wang, Y; Mi, Y; Li, T; Hua, L Mol Bio Rep 2012-10-07 3.40 | Oct 19
Benign Prostate Hyperplasia and Stem Cells: A New Therapeutic Opportunity Notara, M; Ahmed, A Cell Biol Toxicol 2012-10-12 3.40 | Oct 19
The Roots of Cancer: Stem Cells and the Basis for Tumor Heterogeneity Shibata, M; Shen, MM Bioessays 2012-10-02 3.39 | Oct 12
Pro-Survival and Anti-Apoptotic Properties of Androgen Receptor Signaling by Oxidative Stress Promote Treatment Resistance in Prostate Cancer Shiota, M; Yokomizo, A; Naito, S Endocr Relat Cancer 2012-10-02 3.39 | Oct 12
Abiraterone and Novel Antiandrogens: Overcoming Castration Resistance in Prostate Cancer Ferraldeschi, R; Pezaro, C; Karavasilis, V; de Bono, J Annu Rev Med 2012-09-27 3.38 | Oct 5
Prostate Cancer-From Steroid Transformations to Clinical Translation Chang, KH; Sharifi, N Nat Rev Urol 2012-10-02 3.38 | Oct 5
Why Imatinib Remains an Exception of Cancer Research Horne, SD; Stevens, JB; Abdallah, BY; Liu, G; Bremer, SW; Ye, CJ; Heng, HH J Cell Physiol 2012-09-27 3.38 | Oct 5
Non-Metastatic CRPC and Asymptomatic Metastatic CRPC: Which Treatment for Which Patient? Tombal, B Ann Oncol 2012-09-28 3.37 | Sep 28
Androgen Receptor on the Move: Boarding the Microtubule Expressway to the Nucleus Thadani-Mulero, M; Nanus, DM; Giannakakou, P Cancer Res 2012-09-15 3.36 | Sep 21
Targeting the Androgen Receptor Signalling Axis in Castration-Resistant Prostate Cancer Tsao, CK; Galsky, MD; Small, AC; Yee, T; Oh, WK BJU Int 2012-09-18 3.36 | Sep 21
A Perspective on the Role of Estrogen in Hormone-Induced Prostate Carcinogenesis Bosland, MC Cancer Lett 2012-08-29 3.35 | Sep 14
Angiogenesis in Prostate Cancer: Onset; Progression and Imaging Russo, G; Mischi, M; Scheepens, W; De la Rosette, JJ; Wijkstra, H BJU Int 2012-09-07 3.34 | Sep 7
The Reactive Stroma Microenvironment and Prostate Cancer Progression Barron, DA; Rowley, DR Endocr Relat Cancer 2012-08-28 3.33 | Aug 31
Medical Strategies for Treatment of Castration Resistant Prostate Cancer (CRPC) Docetaxel Resistant Altavilla, A; Iacovelli, R; Procopio, G; Alesini, D; Risi, E; Campennì, GM; Palazzo, A; Cortesi, E Cancer Biol Ther 2012-07-24 3.32 | Aug 24
Patterns of Outcome and Toxicity after Salvage Prostatectomy; Salvage Cryosurgery and Salvage Brachytherapy for Prostate Cancer Recurrences after Radiation Therapy: A Multi-Center Experience and Literature Review Peters, M; Moman, MR; van der Poel, HG; Vergunst, H; de Jong, IJ; Vijverberg, PL; Battermann, JJ; Horenblas, S; van Vulpen, M World J Urol 2012-08-18 3.32 | Aug 24